US › Healthcare

Abpro Holdings, Inc. (ABP)

US · Healthcare · Biotechnology

$5.700.00%

Last close · 2026-08-04

Latest quarter · ended 2025-12-31

Revenue

Revenue YoY

-100.0%

Net profit

$5.6M

Profit YoY

+202.3%

EPS

$-0.63

EPS estimate

$-1.20

EPS came in at -0.63 against a street estimate of -1.20 — a beat of 47.5%.

Key statistics

Market cap

$1.4M

Forward P/E

0.0

P/B

0.00

Book value

$-6.04

EPS (TTM)

$-8.25

52-week high

$9.51

52-week low

$0.09

50-day MA

$2.72

200-day MA

$5.62

Beta

-0.00

Analyst view

Analysts rate Abpro Holdings, Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.00.

Shareholding

Insiders

34.93%

Institutions

1.73%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Abpro Holdings, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.